Literature DB >> 15068750

Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Mehdi H Shishehbor1, Stanley L Hazen.   

Abstract

Inflammation and oxidative processes are key components of atherosclerosis, from fatty streak formation to plaque rupture and thrombosis. Recent basic and clinical studies have identified a number of inflammatory and oxidative processes that appear to play a direct role in atherothrombosis and identify potentially clinically useful markers of inflammation and oxidative stress. In this review, we highlight recent results on several of the more promising markers of inflammation for cardiovascular disease risk assessments, such as C-reactive protein, myeloperoxidase, and soluble CD40 ligand and nitrotyrosine, as well as other potential markers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068750     DOI: 10.1007/s11883-004-0038-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  76 in total

Review 1.  Regulation of complement activation by C-reactive protein.

Authors:  C Mold; H Gewurz; T W Du Clos
Journal:  Immunopharmacology       Date:  1999-05

2.  Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk?

Authors:  Irving Kushner; Ashwini R Sehgal
Journal:  Arch Intern Med       Date:  2002-04-22

3.  Statins promote potent systemic antioxidant effects through specific inflammatory pathways.

Authors:  Mehdi H Shishehbor; Marie-Luise Brennan; Ronnier J Aviles; Xiaoming Fu; Marc S Penn; Dennis L Sprecher; Stanley L Hazen
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

4.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

5.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

6.  T-cell-mediated lysis of endothelial cells in acute coronary syndromes.

Authors:  Takako Nakajima; Stephanie Schulte; Kenneth J Warrington; Stephen L Kopecky; Robert L Frye; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

7.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

8.  Antioxidant vitamins and coronary heart disease.

Authors:  D Steinberg
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Authors:  Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  22 in total

1.  SOD inactivation in asthma: bad or no news?

Authors:  Yvonne Janssen-Heininger; Karina Ckless; Niki Reynaert; Albert van der Vliet
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

2.  Increased immune response in mice consuming rice bran oil.

Authors:  Saleta Sierra; Federico Lara-Villoslada; Mónica Olivares; Jesús Jiménez; Julio Boza; Jordi Xaus
Journal:  Eur J Nutr       Date:  2005-02-22       Impact factor: 5.614

Review 3.  Tyrosine-Nitrated Proteins: Proteomic and Bioanalytical Aspects.

Authors:  Carlos Batthyány; Silvina Bartesaghi; Mauricio Mastrogiovanni; Analía Lima; Verónica Demicheli; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2016-07-22       Impact factor: 8.401

4.  Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.

Authors:  Mehdi H Shishehbor; Renliang Zhang; Hector Medina; Marie-Luise Brennan; Danielle M Brennan; Stephen G Ellis; Eric J Topol; Stanley L Hazen
Journal:  Free Radic Biol Med       Date:  2006-09-08       Impact factor: 7.376

Review 5.  Protein nitration in placenta - functional significance.

Authors:  R P Webster; V H J Roberts; L Myatt
Journal:  Placenta       Date:  2008-10-11       Impact factor: 3.481

6.  Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease.

Authors:  Nicole Noren Hooten; Ngozi Ejiogu; Alan B Zonderman; Michele K Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311

7.  Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults.

Authors:  Dalia El-Bejjani; Stanley L Hazen; Wilma Mackay; Nina E Glass; Todd Hulgan; Marisa Tungsiripat; Grace A McComsey
Journal:  HIV Clin Trials       Date:  2008 May-Jun

8.  Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?

Authors:  Mehdi H Shishehbor; Stanley L Hazen
Journal:  Cleve Clin J Med       Date:  2009-01       Impact factor: 2.321

9.  Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.

Authors:  Lixia Zeng; Anna V Mathew; Jaeman Byun; Kevin B Atkins; Frank C Brosius; Subramaniam Pennathur
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.